Aigen Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Aigen Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,674	Closed	-$475K	–	514
2025 Q4	$475K	Buy	37,674 +27,443	+268%	+$314K	0.11%	254
2025 Q3	$102K	Buy	+10,231	New	+$91.8K	0.02%	737
2025 Q2	–	Sell	-15,066	Closed	-$126K	–	773
2025 Q1	$126K	Buy	+15,066	New	+$126K	0.02%	673
2024 Q4	–	Sell	-25,591	Closed	-$213K	–	717
2024 Q3	$213K	Buy	+25,591	New	+$200K	0.04%	569
2023 Q4	–	Sell	-27,905	Closed	-$118K	–	777
2023 Q3	$118K	Buy	+27,905	New	+$104K	0.02%	734
2021 Q2	–	Sell	-33,210	Closed	-$224K	–	452
2021 Q1	$224K	Buy	+33,210	New	+$184K	0.03%	506

Other funds holding AMRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return